2015
DOI: 10.1007/s10048-015-0441-5
|View full text |Cite
|
Sign up to set email alerts
|

Genetic ablation of ataxin-2 increases several global translation factors in their transcript abundance but decreases translation rate

Abstract: Spinocerebellar ataxia type 2 (SCA2) and amyotrophic lateral sclerosis (ALS) are neurodegenerative disorders, caused or modified by an unstable CAG-repeat expansion in the SCA2 gene, which encodes a polyglutamine (polyQ) domain expansion in ataxin-2 (ATXN2). ATXN2 is an RNA-binding protein and interacts with the poly(A)-binding protein PABPC1, localizing to ribosomes at the rough endoplasmic reticulum. Under cell stress, ATXN2, PABPC1 and small ribosomal subunits are relocated to stress granules, where mRNAs a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
43
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 56 publications
(50 citation statements)
references
References 87 publications
7
43
0
Order By: Relevance
“…These reductions may simply be due to less vigorous growth of the clonal fibroblast lines under study and may be unrelated to ataxin-2 effects on translation. However, they certainly coincide with our previously published observation that the incorporation rate of radioactively labelled amino acids is diminished by 34% in Atxn2 -KO MEFs [31]. It can be concluded safely from these data that ataxin-2 is not a prerequisite for ribosome assembly.…”
Section: Resultssupporting
confidence: 91%
See 2 more Smart Citations
“…These reductions may simply be due to less vigorous growth of the clonal fibroblast lines under study and may be unrelated to ataxin-2 effects on translation. However, they certainly coincide with our previously published observation that the incorporation rate of radioactively labelled amino acids is diminished by 34% in Atxn2 -KO MEFs [31]. It can be concluded safely from these data that ataxin-2 is not a prerequisite for ribosome assembly.…”
Section: Resultssupporting
confidence: 91%
“…A previous report from our team showed the ratio of phosphorylated RPS6 versus total RPS6 increased in serum-starved Atxn2 -KO MEFs both at the basal state and after insulin administration [31]. As before, we now found elevated RPS6 phosphorylation in KO-MEFs (Figure 6A).…”
Section: Resultssupporting
confidence: 87%
See 1 more Smart Citation
“…also in hepatocytes (1)(2)(3)(4). The structure of the human ATXN2 protein is characterized (1) by the N-terminal polyQ domain (5), (2) by dispersed proline-rich-domains that mediate association with various SH3-motif containing proteins of the tyrosine kinase receptor endocytosis machinery and thus modulate neuro-trophic signaling (6, 7), (3) by a C-terminal PAM2 motif that mediates interaction with the poly(A)-binding protein PABPC1 that is crucial for mRNA translation (8) and (4) by Lsm and Lsm-AD sequences that mediate the association with RNAs (9 -11).…”
mentioning
confidence: 97%
“…Indeed, although they are not the focus of this work, simple models like yeast, C. elegans and D. melanogaster were among the very first models used and have been crucial to infer on the ubiquitous functions of ataxin-2, such as: the embryonic development (Kiehl et al, 2000; Ciosk et al, 2004); the translation regulation and mRNA metabolism (Mangus et al, 1998; Satterfield and Pallanck, 2006); the regulation of circadian rhythms (Lim and Allada, 2013; Zhang et al, 2013); and modulating the formation of stress granules (Ralser et al, 2005). Likewise, the creation and characterization of two murine KO models of ATXN2 have provided precious new insights into the functions and pathways of this protein (Kiehl et al, 2006; Lastres-Becker et al, 2008a; Huynh et al, 2009; Fittschen et al, 2015; Halbach et al, 2016; Meierhofer et al, 2016) including a putative role in insulin resistance and obesity, which was validated in humans through Genome-wide association studies (Auburger et al, 2014). Finally, the development of iPSCs lines from SCA2 patients was recently reported, as well as CRISPR-Cas9 corrected isogenic iPSCs, to serve as suitable controls.…”
Section: Sca2 Mouse Modelsmentioning
confidence: 99%